Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Cms Shows Strength Technical Breakout Imminent 20260403 1 Why Is Pimco Pty Stock Moving Today Pty Market Analysis 20260410 1 Is Xenon Xene Stock Losing Momentum Price At 56.67 Down 0.32 20260406 Is Cn Finance Cnf Stock A Buy Now Price At 3.27 Down 0.09 20260406 Is Filana Therapeutics Flna Stock Near Resistance Price At 1.68 Down 2.89 20260406 Why Inogen INGN deserves a spot in every portfolio Buying Pressure 20260507 ZeroStack ZSTK Stock Voting Power Investor Interest 20260415 The biggest catalyst for Sleep SNBR nobody is watching 594 20260508 OXLCP Oxford Lane Capital Corp 625 Series 2027 Term Preferred Shares posts 74 Q4 2025 EPS miss shares dip 044 today LIXT Lixte posts Q4 2024 negative EPS of 27 cents and zero revenue with shares unchanged today L3Harris Technologies Inc LHX Positioned for LongTerm Growth Amid Rising Defense Spending on Space and Directed Energy Technologies What Altisource ASPSW does that keeps customers coming back Momentum Fading 20260511 BTSG BrightSpring posts Q4 2025 EPS below estimates shares rise 232 percent on positive investor sentiment GRML Greenland Mines management highlights upcoming rare earth project milestones as key nearterm growth priority ONBPO Old reports narrow Q1 2026 EPS miss shares rise modestly on positive investor sentiment Merck Co MRK Spinoff Organon OGN Q1 2026 Earnings Miss Exposes Structural Growth Headwinds HOVNP Hovnanian reports Q1 2026 profit against expected loss shares edge higher in todays trading NOV NOV posts 68 negative Q1 2026 EPS surprise shares drop nearly 3 in todays trading How QC Technologies QCLS maintains its asset base QC Technologies sees 4268 pct negative EPS miss Swarmer SWMR Climbs 393 Resistance at 3222 in Focus 20260515 Mixed Markets Dow Rises SP and NASDAQ Dip as Tech Leads BTCS Inc BTCS Q1 2026 Earnings Revenue NA Matching Views Best Balance Transfer Credit Cards for May 2026 Extend Your InterestFree Period into 2027 Huntington HII Stock Jumps 107 Approaching 34615 20260518 Bank of NTB Jumps 236 on Strong Momentum 20260518 Valens Semiconductor VLN Rallies 322 as Bulls Target 319 20260514 Inflation Pressures Broaden Beyond Oil and Iran Where Prices Are Rising Now Prediction Markets Signal Growing Probability of Fed Rate Hike by July 2027 AN2 Therapeutics Q1 2026 Earnings Widerthanexpected loss as prerevenue biotech advances pipeline Mamdani Challenges Bezos Over Tax Policy in Heated Exchange on New York Teacher Funding China Confirms Purchase of 200 Boeing Jets Following TrumpXi Summit Tariff Truce Extension in Focus Stellantis Unveils 70 Billion DecadeLong Strategy Commits to 60 New Models Qualcomm Stock Surges on Optimism Over AI Device Boom AnalystFavored Stocks Show Strong Earnings Growth Potential Five Below Fabrinet Alamos Gold Among Seven Picks Enhanced Games Inside the Controversial Steroid Olympics Backed by Donald Trump Jr US Wholesale Inflation Surges 6 Annually in April Marking Sharpest Rise Since 2022 PNTG Q1 2026 Earnings Modest EPS Beat Fails to Lift Stock GSL Q1 2026 Earnings EPS Surpasses Estimates by 314 Amid Market Volatility PSX Q1 2026 Earnings Massive EPS Surprise Drives Shares Higher ICCM Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development Corvex Inc MOVE Q1 2026 Earnings EPS Beat Boosts Shares as Loss Narrows Upwork Inc UPWK Slides 26 as Platform Stock Tests Key Support Faraday Future Warrant FFAIW Continues Slide Trading Near AllTime Lows at 001 EchoStar SATS Slips 33 as Market Weighs Satellite Sector Headwinds Advance Auto Parts AAP Slides Below 58 as Market Sentiment Weighs on Automotive Retailer UGI Corporation UGI Q1 2026 EPS narrowly misses estimates shares dip 101 percent on modest yearoveryear revenue gains What Aeries AERT has done differently this quarter TR Tootsie posts Q3 2023 earnings with no published consensus estimates shares dip 017 in todays session Ford Motor Company F ShortTerm Price Underperformance Amid Broad Market Gains Highlights Compelling PreEarnings Valuation Regeneron Pharmaceuticals REGN Valuation Assessment Following European Dupixent Indication Expansion